Andrew Martin

Dr. Andrew R. Martin is an Associate Professor in Mechanical Engineering and the Director of the Aerosol Research Laboratory of Alberta at the University of Alberta in Edmonton, Canada. He completed his PhD at the University of Alberta in 2008, after which he worked in industrial research and development in France and in the United States. During this period, he was awarded the 2013 Young Investigator Award from the International Society for Aerosols in Medicine (ISAM), recognizing his early contributions to the field of aerosols in medicine. He returned to Alberta to take up his initial academic appointment in 2014, where his research has focused on the development and use of a combination of experimental (in vitro) and computational (in silico) techniques to predict regional drug deposition in the respiratory tract. He is regularly involved in multidisciplinary and international projects, including frequent collaboration with the pharmaceutical industry. He has also made significant contributions in the adjacent field of respiratory support, where his group is developing novel devices and patient interfaces for oxygen therapy and noninvasive ventilation. Collectively, these efforts are motivated by a goal to improve treatment of respiratory diseases by helping to advance new devices and therapies. To date, he has published more than 75 peer-reviewed articles, and is an inventor or co-inventor on 12 granted patents, with patents pending in an additional four patent families. Dr. Martin is a member of the Editorial Board of the Journal of Aerosol Medicine and Pulmonary Drug Delivery, and an Associate Editor of Frontiers in Drug Delivery – Respiratory Drug Delivery. He currently serves as a member of the HQP Program Advisory Committee for the Canadian NanoMedicines Innovation Network, and on the organizing committee of the Canadian Association of Aerosol Researchers, and previously served on the ISAM Executive Board from 2015-2021.